Mutant hypoxiainducible factor 1α modified bone marrow mesenchymal stem cells ameliorate cerebral ischemia

Publisher： Spandidos Publications

E-ISSN： 1791-244X|34|6|1622-1628

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.34, Iss.6, 2014-01, pp. : 1622-1628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human bone marrow native mesenchymal stem cells

By Pontikoglou Charalampos   Delorme Bruno   Charbord Pierre  

Regenerative Medicine, Vol. 3, Iss. 5, 2008-09 ,pp. : 731-741

Future Medicine

Access to resources Recommend Favorite

Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma

By              

International Journal of Molecular Medicine, Vol. 30, Iss. 3, 2012-01 ,pp. : 527-534

Spandidos Publications

Access to resources Recommend Favorite

Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats

By              

International Journal of Molecular Medicine, Vol. 31, Iss. 6, 2013-01 ,pp. : 1395-1401

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of Annexin A1 by short hairpin RNA inhibits the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells

By      

International Journal of Molecular Medicine, Vol. 36, Iss. 2, 2015-01 ,pp. : 406-414

Spandidos Publications

Access to resources Recommend Favorite

Suppression of Evi1 promotes the osteogenic differentiation and inhibits the adipogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1615-1622

Spandidos Publications

Access to resources Recommend Favorite